🇺🇸 FDA
Patent

US 10052362

Glial cell line derived neurotrophic factor, obesity, and obesity-related diseases and conditions

granted A61KA61K38/185

Quick answer

US patent 10052362 (Glial cell line derived neurotrophic factor, obesity, and obesity-related diseases and conditions) held by The United States Geovernment represented by the United States Department of Veterans Affairs expires Mon Aug 16 2038 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The United States Geovernment represented by the United States Department of Veterans Affairs
Grant date
Tue Aug 21 2018 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Aug 16 2038 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
6
CPC classes
A61K, A61K38/185